Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Matthias Scheyer"'
Autor:
Felix Aigner, Ingrid Haunold, Judith Karner-Hanusch, Stefan Riss, Peter Lechner, Max Wunderlich, Andreas Salat, René H. Fortelny, Christoph Kopf, Hubert Hauser, Andreas Heuberger, Markus Glöckler, Konsensusgruppe der Arbeitsgemeinschaft für Coloproktologie (Acp) der Österreichischen Gesellschaft für Chirurgie, Johann Pfeifer, Friedrich Conrad, Matthias Scheyer, Helga Fritsch, S. Roka
Publikováno v:
Wiener klinische Wochenschrift. 124:207-219
Haemorrhoidal disease belongs to the most common benign disorders in the lower gastrointestinal tract. Treatment options comprise conservative as well as surgical therapy still being applied arbitrarily in accordance with the surgeon's expertise. The
Publikováno v:
The American Journal of Surgery. 191:89-93
Background In 1995, Morinaga [1] reported a new technique for the treatment of hemorrhoids, hemorrhoidal artery ligation (HAL), which uses a specially designed proctoscope coupled with a Doppler transducer for identification and ligation of hemorrhoi
Autor:
Felix, Aigner, Friedrich, Conrad, Ingrid, Haunold, Johann, Pfeifer, Andreas, Salat, Max, Wunderlich, Rene, Fortelny, Helga, Fritsch, Markus, Glöckler, Hubert, Hauser, Andreas, Heuberger, Judith, Karner-Hanusch, Christoph, Kopf, Peter, Lechner, Stefan, Riss, Sebastian, Roka, Matthias, Scheyer
Publikováno v:
Wiener klinische Wochenschrift. 124(5-6)
Haemorrhoidal disease belongs to the most common benign disorders in the lower gastrointestinal tract. Treatment options comprise conservative as well as surgical therapy still being applied arbitrarily in accordance with the surgeon's expertise. The
Autor:
Jorge Limão, Matthias Scheyer, Heinrich Penthaler, Luca Busetto, Franz Aigner, Charles de Gheldere, Franco Favretti, Giorgio Gaggiotti, Jacques Himpens, Ernst L. Zurmeyer, Mauro Toppino, Maurizio De Luca, Helmut Weiss, Gianni Segato, Giorgio Bottani
Publikováno v:
Scopus-Elsevier
The Implantable Gastric Stimulator (IGS(R)), a pacemaker-like device, has been found to be safe and effective to induce and maintain weight loss. The LOSS (Laparoscopic Obesity Stimulation Survey) is a prospective non-randomized trial which enrolled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc5c3af0366a56747b302c10b96bcafc
http://hdl.handle.net/11577/1336084
http://hdl.handle.net/11577/1336084